National Comprehensive Cancer Network

The National Comprehensive Cancer Network (NCCN) is enhancing its commitment to patient education by accelerating the annual update schedule for its NCCN Guidelines for Patients. This initiative aims to provide timely, accurate, and accessible information to cancer patients and caregivers, reinforcing NCCN's role as a leader in cancer care guidelines.

The National Comprehensive Cancer Network published new NCCN Clinical Practice Guidelines in Oncology for Pediatric Soft Tissue Sarcomas, specifically focusing on rhabdomyosarcoma. These guidelines are crucial for advancing quality cancer care and are widely adopted by healthcare providers.

The National Comprehensive Cancer Network has appointed Nancy L. Lewis as its new Chief Scientific Officer, which is expected to enhance its research programs, clinical trials, and guideline development, ultimately improving cancer care and patient outcomes globally.

The National Comprehensive Cancer Network's updated guidelines recognize CP-GEP testing, which directly supports the adoption and clinical utility of SkylineDx's Merlin CP-GEP test.

The National Comprehensive Cancer Network published new research in its journal, JNCCN, suggesting that exercise may help cancer patients undergoing chemotherapy. This research reinforces their existing guidelines for survivorship.